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Abstract
Background: Pluripotent cells maintain a unique gene expression pattern and specific chromatin signature. In this
study, we explored the effect of the methyltransferase inhibitor adenosine dialdehyde (AdOx) on pluripotency
maintenance and gene expression in P19 embryonal carcinoma cells.
Results: After AdOx treatment, the pluripotency-related gene network became disordered, and the early
developmental genes were released from the repression. Remarkably, AdOx caused contrasting effects on the
expression of two key pluripotency genes, nanog and oct3/4, with the reduction of the repressive histone marks
H3K27me3, H3K9me3 and H3K9me2 only in the nanog gene.
Conclusions: Key pluripotency genes were controlled by different mechanisms, including the differential
enrichment of repressive histone methylation marks. These data provided novel clues regarding the critical role of
histone methylation in the maintenance of pluripotency and the determination of cell fate in P19 pluripotent cells.
Background
Pluripotent cells, including embryonic stem (ES) cells,
embryonic germ cells, and embryonal carcinoma cells,
are characterized by their ability to differentiate into all
somatic cell types under appropriate conditions [1].
Accordingly, pluripotency-related genes are kept active
in pluripotent cells, and early developmental genes are
maintained in a ‘poised’ state (i.e., repressed but ready
for activation) [2]. Consistent with the wide array of
developmental fates, the chromatin in pluripotent cells
is also highly adaptable [3]. The unique gene expression
pattern and chromatin signature in pluripotent cells are
controlled by a transcription factor network that
involves Oct3/4, Sox2, and Nanog [1]. These three core
factors are tightly regulated, and even limited fluctuation
in their expression may cause significant changes in cell
fate [4,5]. In ES cells, the pluripotency-related genes
have relatively high levels of the active histone mark
H3K4me3 in their chromatin. In contrast, the chromatin
that contains poised developmental genes is associated
with a combination of H3K4me3 and repressive
H3K27me3 marks [2]. Many histone methyltransferases
have been proven to be important for normal embryo-
genesis [6]. Nevertheless, how histone methylation parti-
cipates in the maintenance of pluripotency and
coordinates the precise expression of the core transcrip-
tion factors remains largely unknown.
P19 pluripotent cell line is derived from mouse
embryonal carcinoma that has the ability to contribute
to many normal embryonic tissues after blastocyst infec-
tion [7-10]. When exposed to nontoxic concentrations
of dimethyl sulfoxide (DMSO) in culture conditions,
P19 cells can differentiate into muscle cells. When
induced with all trans-retinoic acid (RA), they can be
directed into neuronal lineage cells [11]. AdOx indir-
ectly inhibits S-adenosylmethionine (SAM)-dependent
methyl-transfer by inhibiting the hydrolysis of the by-
product S-adenosylhomocysteine [12]. AdOx has been
broadly used for the functional analysis of protein
methylation [13]. It has been shown that AdOx treat-
ment during RA induction interferes with the neuronal
differentiation of P19 cells [14].
Here, we show that pre-treatment of AdOx blocks
RA-induced P19 cell neuronal differentiation. The
impact of AdOx on the expression of pluripotency
genes was investigated. We found that in contrast to
decreased Oct3/4, the expression of other key
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P19 cells treated with AdOx. We then specifically exam-
ined the opposing effects of AdOx on the expression of
nanog and oct3/4, which were supported by the differen-
tial repressive histone methylation of these genes. These
results provide an example on the differential control of
pluripotency-related genes by histone methylation in
P19 cells.
Results
AdOx reduces the neuronal lineage potential of P19 cells
To explore whether AdOx affects the maintenance of
pluripotency, we examined the neuronal differentiation
potential of AdOx-treated P19 cells. P19 cells were pre-
treated with AdOx for 1 day and then induced by RA as
shown in Figure 1A. Our data showed that AdOx pre-
treated cells neither aggregated by day 4 nor formed
neuron-like networks by day 8, in contrast to AdOx-null
RA-treated control cells (Figure 1B, bottom vs.t o p
panels). Furthermore, immunostaining showed that
AdOx significantly reduced the expression of neuron-
specific tubulin-isotype b-tubulin III (Tuj1) in RA-
induced P19 cells (Figure 1C, bottom vs. top panels). In
contrast to the almost three quarters of RA-induced
cells that express Tuj1 protein and have extended neur-
ites, only 8% of AdOx-treated cells were Tuj1-positive,
and they had fewer neurites (Figure 1D). Similar results
demonstrating the inhibitory effects of AdOx on RA-
induced expression of Tuj1 were obtained by Western
blotting (Figure 1E). The reduction of Tuj1 was depen-
dent on the dosage of AdOx (Figure 1F). Next, we
investigated whether the neuronal differentiation pro-
gram can be initiated by AdOx pre-treatment. The hier-
archical expression of the transcription factors Ngn1,
Mash1, and NeuroD is essential for neuronal fate deter-
mination [15]. We found that the RA-induced expres-
sion of these early neuronal transcription factors was
remarkably reduced or completely abolished at the
mRNA level in the presence of AdOx (Figure 1G).
These results indicated that the potential for neuronal
fate is severely reduced in AdOx-pretreated P19 cells.
The impact of AdOx on the expression of pluripotency-
related genes in P19 cells
It is important to determine whether the effect of AdOx
is correlated with the maintenance of pluripotency. We
thus examined the expression of pluripotency-related
factors, including Oct3/4, Sox2, Nanog, Fgf4, Utf1, and
Lin28. The analysis showed that Oct3/4 mRNA was
reduced, which is consistent with the reduced differen-
tiation potential. Unexpectedly, Sox2, Nanog, and Fgf4
were markedly up-regulated after AdOx treatment (Fig-
ure 2A). As a control for the pluripotency-related genes,
we examined the impact of AdOx on the mRNA expres-
sion of three germ layer-marker genes as well (Figure
2B), because these genes are maintained in a ‘poised’
state in pluripotent cells that are expressed only when
the three layers are established during early embryonic
development [2]. The mRNA levels of almost all of
these genes in P19 cells increased with AdOx treatment,
whereas the mRNA level of nestin, an ectoderm marker,
did not obviously change. Collectively, these data show
that the expression pattern of pluripotency-related genes
is disordered in AdOx-treated P19 cells and that early
development-related genes are released from their
poised states
AdOx has opposite effects on the expression of Nanog
and Oct3/4
Next, we focused on the differential regulation of pluri-
potency-related genes by AdOx. We examined the
Figure 1 Impact of AdOx pretreatment on RA-induced
differentiation of P19 cells. A. Schematic of the effect of AdOx
pre-treatment on RA-induced P19 cells. B. Microscopic images
showing the impact of AdOx on RA-induced P19 cells. P19 cells
were pre-treated with AdOx (+) or without (-) for 1 day (0 d)
followed by RA treatment for 4 days (4 d) and then cultured in RA-
free medium for another 4 days (8 d). C. Immunostaining for Tuj1
(green) in RA-induced P19 cells pre-treated with AdOx (+) or
without (-). D. Quantification of Tuj1-positive P19 cells induced by
RA and pretreated with AdOx (AdOx) or without (control). E. Impact
of AdOx pretreatment on the expression of Tuj1 and b-actin in RA-
induced P19 cells as shown in Western blots and described as in D.
F. Impact of AdOx concentration on the expression of Tuj1 in P19
cells induced with RA (+) or without (-) as shown in Western blots.
GAPDH and Hsp90a are the loading controls. Numbers indicated
quantification of the Tuj1 western signal relative to GAPDH. Digits at
the bottom of the first row indicates the relative darkness of each
band compared with the control lane set as 1.0. G. RT-qPCR
analyses of ngn1, mash1, and neuroD mRNA expression in P19 cells
pre-treated with AdOx (AdOx) or without (Control) for 1 day (RA 0
d) and then induced with RA (RA 2 d). Each bar in the histograms
of this figure represents a mean value with S.D. from three
independent experiments (mean ± SD). Asterisks represent
significance in statistics: (*) as P < 0.05, (**) for P < 0.01 and (***) for
P < 0.001.
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Oct3/4 and Nanog. AdOx-induced changes in the pro-
tein levels of Nanog and Oct3/4 were similar to those
observed at the mRNA level (Figure 3Avs. 2A). Reporter
plasmids driven by the nanog (-289/+117) and oct3/4
(-2143/+30) promoters weret h e nu s e dt oc o n f i r mt h e
effects of AdOx. It has been reported that these two
reporter plasmids can recapitulate the endogenous
expression of nanog and oct3/4 [16,17]. We found that
t h er e p o r t e ra c t i v i t yd r i v e nb yt h enanog promoter was
increased, whereas that of oct3/4 was reduced in AdOx-
treated P19 cells (Figure 3B). Because they are consis-
tent with the measured mRNA levels, the promoter
activity data suggest that AdOx has opposite effects on
the transcription of the nanog and oct3/4 genes.
Impact of AdOx on the occupation of histone H3K27me3
and H3K9me3 on the nanog and oct3/4 genes
Methylation of histone H3, including H3K27me3,
H3K9me3, and H3K9me2, is usually associated with the
gene repression. We next examined the global effects of
AdOx on these repressive methylation marks and found
that AdOx reduced the level of H3K27me3 and
H3K9me3, but not H3K9me2, in P19 cells (Figure 4A).
To examine whether the nanog and oct3/4 promoters
are associated with repressive methylation marks, ChIP
assays were carried out for H3K27me3, H3K9me3, and
H3K9me2 on five genomic sites that were indicated on
the nanog and oct3/4 genes (Figure 4B). The ChIP data
revealed that all three repressive marks were signifi-
cantly reduced around the nanog gene after AdOx treat-
ment (Figure 4C), but none were affected in the oct3/4
gene (Figure 4D). This result suggested that the AdOx-
mediated reduction in repressive methylation marks on
the nanog gene (but not the oct3/4 gene) is correlated
Figure 3 Impact of AdOx on the expression of Nanog and
Oct3/4 in P19 cells. A. Nanog and Oct3/4 expression in P19 cells
with AdOx (AdOx) or without (Control) as determined by Western
blot. GAPDH is a loading control. Numbers indicated quantification
of the Nanog or Oct3/4 western signal relative to GAPDH
respectively. Digits at the bottom of the first & second row indicate
the relative darkness of each band compared with the control lane
set as 1.0. B. Impact of AdOx on the relative luciferase activity of the
nanog and oct4 promoters. pGL3-nanog-luc (driven by the -289/
+117 fragment of the nanog gene) and pGL-oct3/4-luc (driven by
the -2143/+30 fragment of the oct4 gene) were individually co-
transfected with pRL-TK into P19 cells treated with AdOx or without.
The relative promoter activities showed that AdOx has a different
effect on the two genes in P19 cells. Annotations are as described
in Figure 1G.
Figure 4 Impact of AdOx on H3K27me3, H3K9me3 & H3K9me2
marks on the nanog and oct3/4 genes in P19 cells. A. P19 cells
were treated with the indicated concentrations of AdOx, and the
nuclear extracts were analyzed by Western blot with the indicated
antibodies for specific histone methylation marks. Numbers
indicated quantification of the H3K27me3, K9me3, or K9me2
western signal relative to loading respectively. Digits at the bottom
of the top three rows indicates the relative darkness of each band
compared with the control lane set as 1.0. B. Positions of the primer
pairs used in ChIP assays for analyzing the repressive methylation
marks on the nanog and oct3/4 genes. C&D . Effect of AdOx on
H3K27me3, H3K9me3, or H3K9me2 levels on the nanog (C) and
oct3/4 (D) genes in P19 cells. The positions of the methylated
histone marks to the genes are indicated at the bottom of each
group shown in ChIP assays. IgG is a negative antibody control.
Annotations are as described in Figure 1G.
Figure 2 Impact of AdOx on the expression of pluripotency-
related and germ layer marker genes in P19 cells. A. RT-qPCR
analysis of pluripotency-related genes in P19 cells pretreated with
AdOx for 1 day. The mRNA levels corresponding to each gene are
indicated on top of each panel. B. RT-qPCR analysis of the mRNA
levels of the endodermal (Endo), mesodermal (Meso), ectodermal
(Ecto) and trophectodermal (Tro) marker genes. Annotations for
Figure 2A & 2B are as described for Figure 1G.
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potency-related genes by AdOx in P19 cells.
Discussion
In this study, we demonstrate that AdOx affects the
maintenance of pluripotency in P19 cells. Among the
pluripotency-related genes, nanog and oct3/4 are differ-
entially regulated by AdOx, and their regulation is cor-
related with a differential reduction in repressive histone
methylation marks in these genes.
The SAM-dependent methyltransferase substrates
include lipids, nucleic acids, and a variety of proteins
[13]. The effects of AdOx may be universal. After treat-
ment of P19 cells with AdOx, we observed that in addi-
tion to the aberrant pluripotent gene expression pattern,
AdOx blocked the cell cycle, changed the cell shape and
induced expression of the adhesive molecule E-cadherin
(data not shown). All of these effects may have contrib-
uted to the loss of neuronal potential. In addition, the
nonspecific release of early developmental genes may
also have disturbed the potential for neuronal fate in
P19 cells.
In this study, we examined the expression of six pluri-
potency-associated genes in P19 cells and their changes
in response to AdOx treatment. Utf1 and Lin28 were
not responsive to AdOx. In contrast, Sox2, Nanog, and
Fgf4 showed higher expression levels following AdOx
treatment, whereas the expression of Oct3/4 was
reduced. Nanog, Oct3/4 and Sox2 are all critical tran-
scription factors for pluripotency maintenance, and
Sox2 functions to maintain the identity of neuronal pro-
genitors, suggesting that the core pluripotency transcrip-
tion factors perform distinct roles during embryonic
development [18]. Recently, it was reported that Sox2
and Oct3/4 have opposite effects in defining mesendo-
derm and neural ectoderm [19]. We found that Nanog
and Oct3/4 were differentially regulated by AdOx,
which suggests that they are controlled by different
mechanisms. Consistent with this finding, Nanog and
Oct3/4 play non-overlapping roles in the establishment
of the primitive endoderm and the epiblast [20]. These
clues led us to study the histone methylation of these
two genes.
To maintain pluripotency, the crucial pluripotency
transcription factors are maintained at relatively high
but precisely controlled levels [4,5]. In ES cells, the loca-
lized chromatin regions of poised developmental genes
have both the active histone mark H3K4me3 and the
repressive H3K27me3 mark, whereas the pluripotency-
related genes are mainly occupied by relatively high
levels of H3K4me3 [2]. However, we found repressive
histone methylation marks at pluripotency-related genes
at low levels, implying that they potentially have a role
in the modulation of pluripotency-related genes. The
expression of Nanog in ES cells requires the histone
demethylase Jmjd2C to antagonize the repressive
H3K9me2 [21]. Our ChIP data revealed that AdOx
treatment preferentially causes decreased levels of the
three repressive histone methylation marks H3K9me2,
H3K9me3, and H3K27me3 on the 5’ proximal region of
the nanog gene, whereas it has no effects on the oct3/4
gene. In other words, the repressive histone methyla-
tions are more involved in the regulation of nanog than
in the regulation of oct3/4 in P19 cells. As reported pre-
viously, both nanog and oct3/4 a r eu n d e rt h ec o n t r o lo f
very similar composite sox-oct elements consisting of
neighboring binding sites for Sox2 and Oct3/4 [16,22].
These observations raised interesting questions: how is
the differential regulation of nanog and oct3/4 achieved?
Is the underlying mechanism related to functional differ-
ences between Nanog and Oct3/4? We expect that
further investigations in the fields of ES cells and devel-
oping embryos would confirm our results and answer
the above questions. Because AdOx may also influence
the active histone methylation marks, the methylation of
DNA and on non-histone proteins [13], more specific
manipulations on the relevant histone methyltrans-
ferases would indeed helpful in elucidating the differen-
tial regulation of nanog and oct3/4.
Conclusions
We have shown that the expression of Nanog and Oct3/
4 are differentially regulated by AdOx, with the repres-
sive histone marks reduced only on the nanog gene.
T h e s ed a t as h e dl i g h to nt h ec r i t i c a lr o l eo fh i s t o n e
methylation in the maintenance of pluripotency and the
determination of cell fate in pluripotent cells.
Methods
Cell culture and treatment
P19 cells were cultured in minimum essential medium
( M E M )( I n v i t r o g e n )s u p p l e m e n t e dw i t h1 0 %( v / v )f e t a l
calf serum. For neuronal differentiation, P19 cells were
cultured in medium containing 0.5 μMR A( a l lt r a n s -
retinoic acid, Sigma) for 4 days, and the aggregates were
plated as a monolayer and cultured for another 4 days
in the absence of RA [23]. AdOx pre-treatment involved
adding 20 μM of AdOx (Sigma) to P19 cells for 1 day.
Then, AdOx was removed, and the cells were cultured
with RA.
Antibodies
The following antibodies were used: monoclonal anti-
body against Neuronal Class III b-tubulin (Tuj1) from
Covance, Inc. (MMS435P); antibody against b-actin
(ab8226) from Abcam; antibody against HSP90a from
Stressgen (SPS-771); antibodies against GAPDH
(MAB347) and Sox2 (AB5603) from Chemicon; antibody
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against Oct3/4 from Santa Cruz (sc-5279); antibodies
against trimethyl-Histone H3 (Lys27, 07-449), trimethyl-
Histone H3 (Lys9, 07-442), dimethyl-Histone H3 (Lys9,
07-212), and IgG (12-370) from Upstate Biotech.
Quantitative Real Time RT-PCR analysis
Quantitative Real time RT-PCR assays were carried out
as previously described [24]. The relative expression of
genes was normalized against GAPDH, using the com-
parative CT method according to the manufacturer’s
instructions (Roter-Gene RG-3000A Real-time PCR Sys-
tem, Corbett Research, Australia). Primers used in the
PCR assays are shown in Table 1. The experiments were
repeated at least three times, with statistical analyses for
each individual experimental set. All the values in the
experiments were expressed as the mean ± S.D.
Western blotting
Whole cell extracts (WCEs) were prepared as described
previously [23]. The pellets were washed twice with
RIPA buffer and then resuspended in 500 μlR I P Ab u f -
fer (containing protease inhibitors). After adding SDS to
1%, samples were sonicated for 5 seconds on ice on
high; the clear solutions were then stored as “nuclear
extracts”. The samples were separated in SDS-polyacry-
lamide gels and analyzed as described previously [25].
The density of bands was analyzed and normalized with
internal controls (GAPDH or loading) using AlphaIma-
ger™ 2200 (Alpha Innotech Corp).
Immunofluorescence
The cells were first fixed with 2% paraformaldehyde, per-
meabilized with 0.2% Triton X-100 in PBS for 10 min and
then washed and blocked in 1% goat serum. The cells
were consecutively incubated in 1:100 diluted mouse anti-
Tuj1 antibody at 4°C overnight and the fluorescein isothio-
cyanate (FITC)-conjugated secondary antibody (1:100) at
37°C for 30 min. The cells were then washed and incu-
bated in DAPI (1:3000) for 10 min followed by two PBS
washings. Images were collected using a Nikon Eclipse
TE2000-U microscope. DAPI was used to stain the nuclei
to count the number of cells. The percentage of cells that
were immunoreactive for Tuj1 antigens was determined
by capturing images of random fields. DAPI-stained nuclei
and cells positive for Tuj1 protein were counted.
Luciferase reporter assays
The pGL3-nanog-luc (-289/+117) was from Dr. Paul
Robson [16]. The pGL-oct3/4-luc (-2143/+30) was from
Dr. Duanqing Pei [17]. P19 cells were transfected with
VigoFect Reagent (Vigorous Biotech) according to the
manufacturer’s instructions. pGL3-nanog-luc or pGL-
oct3/4-luc reporter plasmids (0.1 μg) and 0.002 μgo f
control plasmid pRL-TK were co-transfected into the
cells. Twenty-four hours after transfection, the medium
was replaced with fresh a-MEM (AdOx- or AdOx+).
Promoter activity was measured 24 hours later. The
activities of both luciferase reporters were determined
by the Dual-Luciferase Reporter System (Promega)
according to the manufacturer’s instructions. The
Table 1 Primers used in q-RT-PCR analysis
Gene Forward primer Reverse primer
ngn1 CCCTGAAGACGAGGTGAAAAGT CTTGCCATTGTATTGTCAGCCG
mash1 TAACTCCCAACCACTAACAGGC TGAGGAAAGACATCAACCCAGT
neuroD TTCCACGTCAAGCCGC TCGGCGGATGGTTCGT
sox2 CCACCAATCCCATCCA ACCGCCTAACGTACCACT
oct3/4 TCACTCACATCGCCAATCA GTAGCCTCATACTCTTCTCGTT
nanog GGCAGCCCTGATTCTTCTAC CGCTTGCACTTCATCCTTT
lin28 CGGCCAAAAGGGAAGAACAT CATTCCTTGGCATGATGGTCT
fgf4 GGCTTCGGCGGCTCTACT AGGATTCGTAGGCGTTGTAGTTG
utf1 TCCTCTTACGAGCACCGACAC GCAACGCGGTATTCAACGA
gata6 AACAGCAGTGGCTCTGTCCC CTCGGGGTTGGCGTTTT
sox17 TGGGCCAAAGACGAACG TTGGGGTGGTCCTGCATAT
hand1 CTACTTGATGGACGTGCTGG CAACTCCCTTTTCCGCTTG
brachyury CCAGTCTCTGGTCTGTGAGCA GGGGAGCCTCGAAAGAA
pax6 GTGAATGGGCGGAGTTATG ACTTGGACGGGAACTGACA
nestin TGAGAACTCTCGCTTGCAGAC GTATCCCAAGGAAATGCAGC
bmp4 CGAGCCAACACTGTGAGGA GAGGTTGAAGAGGAAACGAAA
cdx2 TCAGGAGGAAAAGTGAGCTG GGCTGTGGAGGCTGTTGTT
gapdh GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTT
Yan et al. BMC Neuroscience 2012, 13:6
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units, were compared to a co-transfected internal con-
trol (pRL-TK). The assay results are shown as the
means ± S.D.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were car-
ried out as described earlier [24]. The primers used in
ChIP-qPCR assays are shown in Table 2. The cycle
quantity required to reach a threshold in the linear
range (Qt) was determined and compared with a stan-
dard curve for the primer set generated by five 10-fold
dilutions of genomic DNA samples of known concentra-
tion. The percentage of immunoprecipitated DNA rela-
tive to input (Input %) was calculated and shown as the
mean ± SD from three independent experiments.
Statistical analysis
Statistical analyses were performed using a two-tailed
Student’s t-test. All of the data are shown as means with
standard deviations. P < 0.05 was considered significant
(*), p < 0.01 was considered highly significant (**) and P
< 0.001 was considered extremely significant (***).
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